Search results
Is Weakness In BioNTech SE (NASDAQ:BNTX) Stock A Sign That The Market Could be Wrong Given Its...
Simply Wall St. via Yahoo Finance· 1 year agoWith its stock down 19% over the past month, it is easy to disregard BioNTech (NASDAQ:BNTX). But if...
BioNTech SE's (NASDAQ:BNTX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market...
Simply Wall St. via Yahoo Finance· 8 months agoWith its stock down 12% over the past month, it is easy to disregard BioNTech (NASDAQ:BNTX)....
Will Weakness in BioNTech SE's (NASDAQ:BNTX) Stock Prove Temporary Given Strong Fundamentals?
Simply Wall St. via Yahoo Finance· 3 months agoWith its stock down 7.5% over the past three months, it is easy to disregard BioNTech (NASDAQ:BNTX)....
BioNTech SE (NASDAQ:BNTX) stock most popular amongst private equity firms who own 44%, while...
Simply Wall St. via Yahoo Finance· 1 year agoA look at the shareholders of BioNTech SE (NASDAQ:BNTX) can tell us which group is most powerful....
BioNTech Trims Expenses As Plummeting Covid Vaccine Sales Still Lag Expectations
Investor's Business Daily· 10 months agoGerman biotech BioNTech said Monday it's trimming drug development costs amid plummeting Covid...
Time To Worry? Analysts Are Downgrading Their BioNTech SE (NASDAQ:BNTX) Outlook
Simply Wall St. via Yahoo Finance· 8 months agoMarket forces rained on the parade of BioNTech SE (NASDAQ:BNTX) shareholders today, when the...
We Ran A Stock Scan For Earnings Growth And BioNTech (NASDAQ:BNTX) Passed With Ease
Simply Wall St. via Yahoo Finance· 1 year agoFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a...
BioNTech SE's (NASDAQ:BNTX) largest shareholders are private equity firms with 43% ownership,...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights The considerable ownership by private equity firms in BioNTech indicates that they...
BioNTech Dives As Pfizer Partner Reports Lagging Covid Vaccine Sales, Guidance
Investor's Business Daily· 2 years agoGerman Covid vaccine developer BioNTech lagged second-quarter estimates and reiterated disappointing...
BioNTech Stock Surges On Surprise Profit, Strong Sales. But Report Has Downside.
Investor's Business Daily· 7 months agoCovid vaccine maker BioNTech reported a surprise profit and better-than-expected September-quarter...